The Wall Street Journal: Abbott Labs reportedly aware of problems at baby-formula factory in Michigan months earlier than known


STURGIS, Mich. — Abbott Laboratories was alerted to allegations concerning problems at an infant-formula plant months earlier than previously publicly known, according to a government official, a person familiar with the matter and documents viewed by the Wall Street Journal.

A complaint filed under the U.S. Labor Department’s Occupational Safety and Health Administration’s whistleblower-protection program by a former Abbott employee in February 2021 alleged a host of problems at the company’s Sturgis plant. They included failing equipment in need of repair and formula released without adequate evidence that it was safe for consumption, the person familiar with the matter said.

This article was originally published by Read the original article here.

Previous articleU.S. crude-oil inventories rise, but gasoline supply declines
Next articleGold finishes higher Wednesday, even as dollar and Treasury yields rise


Please enter your comment!
Please enter your name here